Alpha-7 nicotinic receptor agonists: potential new candidates for the treatment of schizophrenia.
Martin LF, Kem WR, Freedman R. Alpha-7 nicotinic receptor agonists: potential new candidates for the treatment of schizophrenia. Psychopharmacology (Berl). 2004 Jun; 174(1):54-64.